Crocetin
Application Notes
Crocetin was found to inhibit cell cycle progression at the G2-M phase and pancreatic tumor formation in nude mice. It has been shown to improve postshock recovery of cellular adenosine triphosphate (ATP). It also inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Inhibitor of cell cycle progression
SKU | 02193543-CF |
Alternate Names | 8,8´-Diapocarotenedioic acid; 2,6,11,15-Tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedoic acid |
Application Notes | Crocetin was found to inhibit cell cycle progression at the G2-M phase and pancreatic tumor formation in nude mice. It has been shown to improve postshock recovery of cellular adenosine triphosphate (ATP). It also inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. |
Base Catalog Number | 193543 |
Biochemical Physiological Actions | Crocetin may provide neuroprotection in rats by reducing the production of various neurotoxic molecules. |
CAS # | 27876-94-4 |
Format | Powder |
Molecular Formula | C20H24O4 |
Molecular Weight | 328.408 g/mol |
Source | Gardenia jasminoides ellis |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |